Results of a non-specific immunomodulation therapy in chronic heart failure (ACCLAIM trial): a placebo-controlled randomised trial.

Torre-Amione, Guillermo; Anker, Stefan D; Bourge, Robert C; Colucci, Wilson S; Greenberg, Barry H; Hildebrandt, Per; Keren, Andre; Motro, Michael; Moyé, Lemuel A; Otterstad, Jan Erik; Pratt, Craig M; Ponikowski, Piotr; Rouleau, Jean Lucien; Sestier, Francois; Winkelmann, Bernhard R; Young, James B

Torre-Amione, Guillermo; Anker, Stefan D; Bourge, Robert C; Colucci, Wilson S; Greenberg, Barry H; Hildebrandt, Per; Keren, Andre; Motro, Michael; Moyé, Lemuel A; Otterstad, Jan Erik; Pratt, Craig M; Ponikowski, Piotr; Rouleau, Jean Lucien; Sestier, Francois; Winkelmann, Bernhard R; Young, James B.

Affiliation

Torre-Amione G; Heart Transplant Program, Methodist DeBakey Heart Center, Methodist Hospital, Houston, TX 77030, USA. gtorre@tmhs.org

Lancet ; 371(9608): 228-36, 2008 Jan 19.

Article in En | MEDLINE | ID: mdl-18207018

Subject(s)

Endpoint Determination/methods; Heart Failure/therapy; Immunologic Factors/therapeutic use; Aged; Chronic Disease; Double-Blind Method; Female; Heart Failure/classification; Heart Failure/physiopathology; Hospital Mortality; Humans; Immunologic Factors/adverse effects; Male; Middle Aged; Severity of Illness Index

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Endpoint Determination / Heart Failure / Immunologic Factors Type of study: Clinical_trials Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Lancet Year: 2008 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google